Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02269267Phase 2Completed
The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)
Leukemia, Myeloid, Chronic
PrincipalinvestigatorStart date: 2014-12-18

Research Network

Collaboration Network

12 collaborators·11 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Medical College of Wisconsin

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Beata Holkova, MD

Massey Cancer Center

Moderately Similar
3 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score30%

K A Bradstock), Dr.

Westmead Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score30%

J Szer, Dr.

Royal Melbourne Hospital, Parkville, Australia

Moderately Similar
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score30%

E Gluckman, Dr.

Hopital St Louis, Paris, France

Moderately Similar
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score30%

J Rowe, Dr.

Rambam Medical Center, Haifa, Israel

Moderately Similar
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score30%

G Lambertenghi-Deliliers, Dr.

Padiglione G Marcora, Ospedale Maggiore di Milano, Italy

Moderately Similar
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score30%

T Ruutu, Dr.

Helsinki University CT. Rentral Hospital, Finland

Moderately Similar
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score30%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Moderately Similar
24 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score30%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Moderately Similar
14 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score30%

Qifa Liu

Nanfang Hospital, Southern Medical University

Moderately Similar
33 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02269267Phase 2PrincipalInvestigator

The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)

Leukemia, Myeloid, Chronic
Completed

All 1 trials loaded